Patent ID: 7638124

Claim:
A method of killing or damaging a target human cell expressing or displaying a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen, the method comprising exposing the target cell to a composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region which includes amino acid sequences as set forth in SEQ ID NOs:20 (CDR1), 21 (CDR2) and 22 (CDR3) in a heavy chain of the antibody, and amino acid sequences as set forth in SEQ ID NOs:23 (CDR1), 24 (CDR2) and 25 (CDR3) in a light chain of the antibody, said amino acid sequences being in a context of framework sequences, and a domain allowing said antibody or antibody fragment to kill the target human cell, thereby killing or damaging the target human cell expressing or displaying the complex composed of the human antigen-presenting molecule and the antigen derived from the pathogen.